Literature DB >> 23037877

Burn injuries.

Steffen Rex1.   

Abstract

PURPOSE OF REVIEW: To summarize and highlight recent advances in the understanding and management of burn injuries. RECENT
FINDINGS: The review focuses on topics which are of particular relevance for critical care practitioners involved in burn care: resuscitation, management of infection and sepsis, epidemiology and outcome, and organization and costs of burn care.
SUMMARY: While being the mainstay of early survival in burn victims, various aspects of burn resuscitation are still contentious and highlighted in this review. In particular, several strategies to overcome the repeatedly observed 'fluid creep' in burn patients are discussed, including the use of computerized resuscitation algorithms and the administration of colloids. Sepsis and multiorgan failure have become the major causes of death in patients surviving the initial phase of burn shock. Various aspects of sepsis management are reviewed, amongst which diagnosis, antibiotic treatment and prophylaxis. Recent epidemiologic data allow to identify risk factors associated with mortality as these are potentially amenable to targeted prevention and therapy. Examples are acute kidney injury and sepsis. The overview is completed by recent findings on organization and costs of burn care, including the adherence to referral criteria and the main determinants of cost.

Entities:  

Mesh:

Year:  2012        PMID: 23037877     DOI: 10.1097/MCC.0b013e328359fd6e

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  8 in total

1.  Ten tips for managing critically ill burn patients: follow the RASTAFARI!

Authors:  Matthieu Legrand; Anne Berit Guttormsen; Mette M Berger
Journal:  Intensive Care Med       Date:  2015-01-09       Impact factor: 17.440

2.  Timeline of health care-associated infections and pathogens after burn injuries.

Authors:  David van Duin; Paula D Strassle; Lauren M DiBiase; Anne M Lachiewicz; William A Rutala; Timothy Eitas; Robert Maile; Hajime Kanamori; David J Weber; Bruce A Cairns; Sonia Napravnik; Samuel W Jones
Journal:  Am J Infect Control       Date:  2016-10-11       Impact factor: 2.918

3.  Burn plus lipopolysaccharide augments endoplasmic reticulum stress and NLRP3 inflammasome activation and reduces PGC-1α in liver.

Authors:  Li Diao; Alexandra H Marshall; Xiaojing Dai; Elena Bogdanovic; Abdikarim Abdullahi; Saeid Amini-Nik; Marc G Jeschke
Journal:  Shock       Date:  2014-02       Impact factor: 3.454

4.  Five Years Experience With Meek Grafting in the Management of Extensive Burns in an Adult Burn Center.

Authors:  Khosrow Siamak Houschyar; Christian Tapking; Ina Nietzschmann; Susanne Rein; Kristian Weissenberg; Malcolm Pyles Chelliah; Dominik Duscher; Zeshaan Naeem Maan; Hubertus Maria Philipps; Clifford Charles Sheckter; Beate Reichelt; Ludwik Krzysztof Branski; Frank Siemers
Journal:  Plast Surg (Oakv)       Date:  2018-11-21       Impact factor: 0.947

5.  Smoke Inhalation in a Rural Emergency Setting: A Simulation Session.

Authors:  Robert Jong; Eugene Krustev; Aron Heroux; Adam Dubrowski
Journal:  Cureus       Date:  2016-09-15

Review 6.  Application of Phagotherapy in the Treatment of Burn Patients (Review).

Authors:  А E Leontyev; I V Pavlenko; О V Kovalishena; N V Saperkin; А А Tulupov; V V Beschastnov
Journal:  Sovrem Tekhnologii Med       Date:  2020-06-28

Review 7.  The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm Pseudomonas aeruginosa in Multiple Disease Settings Including Cystic Fibrosis, Burns/Wounds and Urinary Tract Infections.

Authors:  Daniel J Hassett; Rhett A Kovall; Michael J Schurr; Nalinikanth Kotagiri; Harshita Kumari; Latha Satish
Journal:  Front Microbiol       Date:  2021-06-17       Impact factor: 5.640

8.  Enteral resuscitation with oral rehydration solution to reduce acute kidney injury in burn victims: Evidence from a porcine model.

Authors:  Belinda I Gómez; Matthew K McIntyre; Jennifer M Gurney; Kevin K Chung; Leopoldo C Cancio; Michael A Dubick; David M Burmeister
Journal:  PLoS One       Date:  2018-05-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.